Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article December 18 2024
Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Multiple Myeloma
Research Article December 18 2024
Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis
Research Article December 18 2024
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly-diagnosed patients: impact and outcome
Research Article December 18 2024
Improved Overall Survival with Checkpoint Inhibition and Allogeneic Transplantation in Relapsed Hodgkin Lymphoma
Research Article December 13 2024
Physiological significance of antithrombin D-helix interaction with vascular GAGs
Research Article December 13 2024
Membrane-bound model of the ternary complex between factor VIIa/tissue factor and factor X
Research Article December 11 2024
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA
Research Article December 11 2024
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
Research Article December 10 2024
JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms
Research Article December 10 2024
Health care Systems as Determinants of Outcomes in Multiple Myeloma: Final Results from the Latin American MYLACRE Study
Research Article December 10 2024
Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis
Review Article December 9 2024
The Roadmap to Integrate Diversity, Equity, and Inclusion in Hematology Clinical Trials: An American Society of Hematology Initiative
Research Article December 6 2024
Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management in people with hemophilia A or B
Letter December 5 2024
Nonclinical evaluation of HBG1/2 and BCL11A as genome editing targets for the treatment of β-hemoglobinopathies
Research Article December 5 2024
Trial eligibility, treatment patterns and outcome for venetoclax-based therapy in AML: a prospective cohort study
Research Article December 5 2024
Prognostic Impact of Patient-Reported Symptoms in Multiple Myeloma
Research Article December 5 2024
Advantages of a genomic DNA-based NGS assay for detection of mutant NPM1 measurable residual disease in AML
Review Article December 4 2024
Dual targeting CAR-T cells for B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin lymphoma
Research Article December 4 2024
Impact of Measurable Residual Disease Clearance Kinetics in Patients with AML Undergoing Intensive Chemotherapy
Review Article December 4 2024
New Strategies for Enhancing Enrollment of Underrepresented Minorites in Lymphoma Clinical Trials
Review Article December 4 2024
Building Capacity for Pediatric Hematological Diseases in Sub-Saharan Africa
Letter December 4 2024
Venetoclax-Proteasome inhibitor-Dexamethasone for unfit patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
Research Article December 3 2024
Peripheral Neuropathy in the Phase 3 ASPEN Study of Bruton Tyrosine Kinase Inhibitors for Waldenström Macroglobulinemia
Research Article December 3 2024
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
Research Article December 3 2024
Antiviral potential of Vδ2 T-cells in children given TCR αβ/CD19 cell depleted HLA-haploidentical HSCT
Research Article December 3 2024
Inaticabtagene Autoleucel (CNCT19) in adult relapsed or refractory B-cell acute lymphoblastic leukemia
Research Article December 3 2024
Anxiety and Depression in Patients with Histiocytic Neoplasms and their Associated Clinical Features
Research Article December 3 2024
TIFAB Modulates Metabolic Pathways in KMT2A::MLLT3-Induced AML Through HNF4A
Research Article November 27 2024
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium
Letter November 27 2024
Generalized Additive Logit Models for Clinical Prediction
Research Article November 27 2024
COMPARABLE OUTCOMES AFTER BUSULFAN- OR TREOSULFAN-BASED CONDITIONING FOR ALLO-HSCT IN CHILDREN WITH ALL-RESULTS OF FORUM
Reply November 27 2024
GALMs confirm predictive power of thromboinflammation in STEMI
Review Article November 27 2024
Is Allogeneic Transplantation for Sickle Cell Disease Still Relevant in the Era of Gene Therapy?
Letter November 27 2024
Genomic landscape of testicular follicular lymphoma is characterized by frequent 1p36/TNFRSF14 alterations
Research Article November 21 2024
Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
Research Article November 21 2024
Incidence and Characterization of Secondary CNS Lymphoma in 1,972 Patients with DLBCL - A Danish Nationwide Cohort Study
Research Article November 21 2024
Chronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia
Research Article November 20 2024
PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
Research Article November 19 2024
Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia
Research Article November 19 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis
Review Article November 19 2024
Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL
Research Article November 15 2024
ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.
Research Article November 13 2024
Utility of Caregiver Signaling Questions to Detect Neurocognitive Impairment in Children with Sickle Cell Disease
Research Article November 13 2024
Identification of Genomic Biomarkers of Disease Progression and Survival in Primary CNS Lymphoma
Letter November 13 2024
Pediatric refractory ITP, a definition to be defined
Research Article November 6 2024
Validation of the Revised 2022 European LeukemiaNet Risk Stratification in Adult Patients with Acute Myeloid Leukemia
Research Article November 6 2024
Donor age contributes more to the rheological properties of stored red blood cells than donor sex and biological age
Research Article October 29 2024
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease
Research Article October 25 2024
Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS
Reply October 25 2024
Reply to Letter to Editor by Fingrut, et al
Page 3 of 4
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals